1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Immunic Inc (IMUX)
  7. Quote

IMUX IMUX

Immunic Stock Price

8.61
0.00 (0.0%)
8.61
Volume 0
Bid Price 8.25
Ask Price 9.99
News -
Day High

Low
6.96

52 Week Range

High
28.2138

Day Low
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Immunic Inc IMUX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 8.61 07:00:00
Open Price Low Price High Price Close Price Prev Close
8.61
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 8.61 USD

Period:

Draw Mode:

Immunic Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 226.01M 26.25M 23.42M $ - $ - -2.85 -2.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 3.50k 2.40%

more financials information »

Immunic News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IMUX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week9.359.488.428.94250,033-0.74-7.91%
1 Month9.3210.508.429.41155,448-0.71-7.62%
3 Months10.0410.506.968.62209,395-1.43-14.24%
6 Months13.5515.126.969.75219,853-4.94-36.46%
1 Year17.8028.21386.9613.13213,359-9.19-51.63%
3 Years22.0028.21384.1914.49216,396-13.39-60.86%
5 Years22.0028.21384.1914.49216,396-13.39-60.86%

Immunic Description

Immunic Inc is a clinical stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, IMU-838 is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH, IMU-935 is an inverse agonist of RORyt and IMU-856 targets the restoration of the intestinal barrier function.


Your Recent History
NASDAQ
IMUX
Immunic
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.